Quick Answer
P3 Health Partners Inc. reported Cash and Equivalents of $25.01 million for fiscal year 2025.
P3 Health Partners Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $25.01M | -35.6% |
| 2024 | $38.82M | +6.9% |
| 2023 | $36.32M | +107.1% |
| 2022 | $17.54M | -87.5% |
| 2021 | $140.48M | +2550.0% |
| 2021 | $5.30M | -85.4% |
| 2020 | $36.26M | +11.3% |
| 2019 | $32.59M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $37.71M | -40.1% | -2.2% |
| June 30, 2025 | $38.58M | -47.2% | -3.7% |
| March 31, 2025 | $40.08M | +46.8% | +3.3% |
| December 31, 2024 | $38.82M | +6.9% | -38.4% |
| September 30, 2024 | $62.96M | +19.8% | -13.9% |
| June 30, 2024 | $73.09M | +22.0% | +167.7% |
| March 31, 2024 | $27.30M | +280.1% | -24.8% |
| December 31, 2023 | $36.32M | +107.1% | -30.9% |
- P3 Health Partners Inc. showed a decrease of -35.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, P3 Health Partners Inc.’s cash and equivalents has declined by 23.3% (from $32.59 million to $25.01 million).
- The most recent figure is from P3 Health Partners Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: